Aaron Collins

And I think that's the jarring aspect of it is that it's gone now and you're not going to get it back and you have no way to prepare for tomorrow.

The mute button escapes me.

I'm here.

I think I have to echo Matthew's sentiment.

think it is extremely troubling, stress-inducing.

It is a topic of conversation every day at work.

And I have to... I spoke on the professional side of things earlier, but there are personal side to these things too.

I volunteer with Breakthrough T1D, an organization that is...

really focused on finding a cure for type 1 diabetes, which I have.

And some of these cuts to the FDA and the NIH have ceased research clinical trials that were in the final phase three stages of curing people with type 1 diabetes.

So for me, knowing about these research opportunities that have stopped and will not make it to the public as quickly as they could have been is also feeling like I've been stripped of something.

That is also just mind-boggling to me that there are clinical trials out there that have just stopped.

because that's what he wanted.

And it's not just type 1 diabetes.

There's a whole slew of other things.

Sheridan brought up childhood cancer research.

Who wants the kids to have cancer?

It's just mind-boggling that these are the things that we're choosing to just stop.

And I wonder a lot of the times if advisors or people in the inner circle helping make these decisions are laying out the programs and things that are going to be affected by these choices.

And my gut says probably not.